img

Global Revlimid Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Revlimid Market Research Report 2024

REVLIMID® (lenalidomide), an immunomodulatory therapy used to treat people with multiple myeloma
According to Mr Accuracy reports new survey, global Revlimid market is projected to reach US$ 6006.3 million in 2029, increasing from US$ 10350 million in 2022, with the CAGR of -5.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Revlimid market research.
Revlimid, an oral medication used in the treatment of multiple myeloma and other blood cancers, is experiencing increasing demand. Factors driving market growth include the rising incidence of blood cancers, advancements in treatment options, and the expanding geriatric population. Key players in the market are focusing on expanding the indications of Revlimid and conducting clinical trials for new indications. Additionally, strategic collaborations and mergers are contributing to market expansion. However, challenges such as patent expirations and the availability of generic alternatives may impact market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Revlimid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bristol Myers Squibb
Teva
Natco
Segment by Type
10mg
25mg
Other

Segment by Application


Hospital
Drugs Store
Other

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Revlimid report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Revlimid Market Overview
1.1 Product Overview and Scope of Revlimid
1.2 Revlimid Segment by Type
1.2.1 Global Revlimid Market Value Comparison by Type (2024-2034)
1.2.2 10mg
1.2.3 25mg
1.2.4 Other
1.3 Revlimid Segment by Application
1.3.1 Global Revlimid Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Revlimid Market Size Estimates and Forecasts
1.4.1 Global Revlimid Revenue 2018-2029
1.4.2 Global Revlimid Sales 2018-2029
1.4.3 Global Revlimid Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Revlimid Market Competition by Manufacturers
2.1 Global Revlimid Sales Market Share by Manufacturers (2018-2024)
2.2 Global Revlimid Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Revlimid Average Price by Manufacturers (2018-2024)
2.4 Global Revlimid Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Revlimid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Revlimid, Product Type & Application
2.7 Revlimid Market Competitive Situation and Trends
2.7.1 Revlimid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Revlimid Players Market Share by Revenue
2.7.3 Global Revlimid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Revlimid Retrospective Market Scenario by Region
3.1 Global Revlimid Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Revlimid Global Revlimid Sales by Region: 2018-2029
3.2.1 Global Revlimid Sales by Region: 2018-2024
3.2.2 Global Revlimid Sales by Region: 2024-2029
3.3 Global Revlimid Global Revlimid Revenue by Region: 2018-2029
3.3.1 Global Revlimid Revenue by Region: 2018-2024
3.3.2 Global Revlimid Revenue by Region: 2024-2029
3.4 North America Revlimid Market Facts & Figures by Country
3.4.1 North America Revlimid Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Revlimid Sales by Country (2018-2029)
3.4.3 North America Revlimid Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Revlimid Market Facts & Figures by Country
3.5.1 Europe Revlimid Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Revlimid Sales by Country (2018-2029)
3.5.3 Europe Revlimid Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Revlimid Market Facts & Figures by Country
3.6.1 Asia Pacific Revlimid Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Revlimid Sales by Country (2018-2029)
3.6.3 Asia Pacific Revlimid Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Revlimid Market Facts & Figures by Country
3.7.1 Latin America Revlimid Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Revlimid Sales by Country (2018-2029)
3.7.3 Latin America Revlimid Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Revlimid Market Facts & Figures by Country
3.8.1 Middle East and Africa Revlimid Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Revlimid Sales by Country (2018-2029)
3.8.3 Middle East and Africa Revlimid Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Revlimid Sales by Type (2018-2029)
4.1.1 Global Revlimid Sales by Type (2018-2024)
4.1.2 Global Revlimid Sales by Type (2024-2029)
4.1.3 Global Revlimid Sales Market Share by Type (2018-2029)
4.2 Global Revlimid Revenue by Type (2018-2029)
4.2.1 Global Revlimid Revenue by Type (2018-2024)
4.2.2 Global Revlimid Revenue by Type (2024-2029)
4.2.3 Global Revlimid Revenue Market Share by Type (2018-2029)
4.3 Global Revlimid Price by Type (2018-2029)
5 Segment by Application
5.1 Global Revlimid Sales by Application (2018-2029)
5.1.1 Global Revlimid Sales by Application (2018-2024)
5.1.2 Global Revlimid Sales by Application (2024-2029)
5.1.3 Global Revlimid Sales Market Share by Application (2018-2029)
5.2 Global Revlimid Revenue by Application (2018-2029)
5.2.1 Global Revlimid Revenue by Application (2018-2024)
5.2.2 Global Revlimid Revenue by Application (2024-2029)
5.2.3 Global Revlimid Revenue Market Share by Application (2018-2029)
5.3 Global Revlimid Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Revlimid Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Bristol Myers Squibb Revlimid Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Revlimid Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Teva Revlimid Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Natco
6.3.1 Natco Corporation Information
6.3.2 Natco Description and Business Overview
6.3.3 Natco Revlimid Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Natco Revlimid Product Portfolio
6.3.5 Natco Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Revlimid Industry Chain Analysis
7.2 Revlimid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Revlimid Production Mode & Process
7.4 Revlimid Sales and Marketing
7.4.1 Revlimid Sales Channels
7.4.2 Revlimid Distributors
7.5 Revlimid Customers
8 Revlimid Market Dynamics
8.1 Revlimid Industry Trends
8.2 Revlimid Market Drivers
8.3 Revlimid Market Challenges
8.4 Revlimid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Revlimid Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Revlimid Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Revlimid Market Competitive Situation by Manufacturers in 2022
Table 4. Global Revlimid Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Revlimid Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Revlimid Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Revlimid Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Revlimid Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Revlimid, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Revlimid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Revlimid, Product Type & Application
Table 12. Global Key Manufacturers of Revlimid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Revlimid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Revlimid as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Revlimid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Revlimid Sales by Region (2018-2024) & (K Units)
Table 18. Global Revlimid Sales Market Share by Region (2018-2024)
Table 19. Global Revlimid Sales by Region (2024-2029) & (K Units)
Table 20. Global Revlimid Sales Market Share by Region (2024-2029)
Table 21. Global Revlimid Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Revlimid Revenue Market Share by Region (2018-2024)
Table 23. Global Revlimid Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Revlimid Revenue Market Share by Region (2024-2029)
Table 25. North America Revlimid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Revlimid Sales by Country (2018-2024) & (K Units)
Table 27. North America Revlimid Sales by Country (2024-2029) & (K Units)
Table 28. North America Revlimid Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Revlimid Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Revlimid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Revlimid Sales by Country (2018-2024) & (K Units)
Table 32. Europe Revlimid Sales by Country (2024-2029) & (K Units)
Table 33. Europe Revlimid Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Revlimid Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Revlimid Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Revlimid Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Revlimid Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Revlimid Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Revlimid Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Revlimid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Revlimid Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Revlimid Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Revlimid Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Revlimid Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Revlimid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Revlimid Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Revlimid Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Revlimid Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Revlimid Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Revlimid Sales (K Units) by Type (2018-2024)
Table 51. Global Revlimid Sales (K Units) by Type (2024-2029)
Table 52. Global Revlimid Sales Market Share by Type (2018-2024)
Table 53. Global Revlimid Sales Market Share by Type (2024-2029)
Table 54. Global Revlimid Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Revlimid Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Revlimid Revenue Market Share by Type (2018-2024)
Table 57. Global Revlimid Revenue Market Share by Type (2024-2029)
Table 58. Global Revlimid Price (USD/Unit) by Type (2018-2024)
Table 59. Global Revlimid Price (USD/Unit) by Type (2024-2029)
Table 60. Global Revlimid Sales (K Units) by Application (2018-2024)
Table 61. Global Revlimid Sales (K Units) by Application (2024-2029)
Table 62. Global Revlimid Sales Market Share by Application (2018-2024)
Table 63. Global Revlimid Sales Market Share by Application (2024-2029)
Table 64. Global Revlimid Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Revlimid Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Revlimid Revenue Market Share by Application (2018-2024)
Table 67. Global Revlimid Revenue Market Share by Application (2024-2029)
Table 68. Global Revlimid Price (USD/Unit) by Application (2018-2024)
Table 69. Global Revlimid Price (USD/Unit) by Application (2024-2029)
Table 70. Bristol Myers Squibb Corporation Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Revlimid Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Bristol Myers Squibb Revlimid Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Revlimid Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Teva Revlimid Product
Table 79. Teva Recent Developments/Updates
Table 80. Natco Corporation Information
Table 81. Natco Description and Business Overview
Table 82. Natco Revlimid Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Natco Revlimid Product
Table 84. Natco Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Revlimid Distributors List
Table 88. Revlimid Customers List
Table 89. Revlimid Market Trends
Table 90. Revlimid Market Drivers
Table 91. Revlimid Market Challenges
Table 92. Revlimid Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Revlimid
Figure 2. Global Revlimid Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Revlimid Market Share by Type in 2022 & 2029
Figure 4. 10mg Product Picture
Figure 5. 25mg Product Picture
Figure 6. Other Product Picture
Figure 7. Global Revlimid Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Revlimid Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Drugs Store
Figure 11. Other
Figure 12. Global Revlimid Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Revlimid Market Size (2018-2029) & (US$ Million)
Figure 14. Global Revlimid Sales (2018-2029) & (K Units)
Figure 15. Global Revlimid Average Price (USD/Unit) & (2018-2029)
Figure 16. Revlimid Report Years Considered
Figure 17. Revlimid Sales Share by Manufacturers in 2022
Figure 18. Global Revlimid Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Revlimid Players: Market Share by Revenue in 2022
Figure 20. Revlimid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Revlimid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Revlimid Sales Market Share by Country (2018-2029)
Figure 23. North America Revlimid Revenue Market Share by Country (2018-2029)
Figure 24. the United States Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Revlimid Sales Market Share by Country (2018-2029)
Figure 27. Europe Revlimid Revenue Market Share by Country (2018-2029)
Figure 28. Germany Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. UK Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Revlimid Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Revlimid Revenue Market Share by Region (2018-2029)
Figure 35. China Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Revlimid Sales Market Share by Country (2018-2029)
Figure 45. Latin America Revlimid Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Revlimid Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Revlimid Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Revlimid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Revlimid by Type (2018-2029)
Figure 55. Global Revenue Market Share of Revlimid by Type (2018-2029)
Figure 56. Global Revlimid Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Revlimid by Application (2018-2029)
Figure 58. Global Revenue Market Share of Revlimid by Application (2018-2029)
Figure 59. Global Revlimid Price (USD/Unit) by Application (2018-2029)
Figure 60. Revlimid Value Chain
Figure 61. Revlimid Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed